Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis

Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described. Medical charts were retrospectively reviewed for all cases of culture-confirmed, INH-monoresistant tuberculosis ( n = 137) reported to the San Francisco Departmen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases Jg. 48; H. 2; S. 179
Hauptverfasser:	Cattamanchi, Adithya, Dantes, Raymund B, Metcalfe, John Z, Jarlsberg, Leah G, Grinsdale, Jennifer, Kawamura, L Masae, Osmond, Dennis, Hopewell, Philip C, Nahid, Payam
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 15.01.2009
Schlagworte:	Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Drug Resistance, Bacterial Female Humans Isoniazid - pharmacology Male Middle Aged Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - isolation & purification Pyrazinamide - adverse effects Pyrazinamide - therapeutic use San Francisco Treatment Outcome Tuberculosis - drug therapy Tuberculosis - microbiology Tuberculosis - physiopathology San Francisco
ISSN:	1537-6591, 1537-6591
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!